Arcadia Biosciences, Inc. (RKDA) stock
RKDANasdaqBeveragesFiscal year ends December 31
$0.19−0.00 (-2.01%)
Close on Nov 17, 2026Market cap $457.03KP/E –Yield –
Arcadia Biosciences operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
Arcadia Biosciences's operating cash flow for the twelve months ending Jun 30, 2026 was -$2.50M. For fiscal 2025 it was -$4.70M. The highest annual figure on record is -$4.70M in fiscal 2025.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$4.70M | – |
| FY2024 | Dec 31, 2024 | -$9.63M | – |
| FY2023 | Dec 31, 2023 | -$15.29M | – |
| FY2022 | Dec 31, 2022 | -$13.98M | – |
| FY2021 | Dec 31, 2021 | -$25.87M | – |
| FY2020 | Dec 31, 2020 | -$30.22M | – |
| FY2019 | Dec 31, 2019 | -$17.20M | – |
| FY2018 | Dec 31, 2018 | -$13.63M | – |
| FY2017 | Dec 31, 2017 | -$13.97M | – |
| FY2016 | Dec 31, 2016 | -$17.06M | – |
| FY2015 | Dec 31, 2015 | -$15.11M | – |
| FY2014 | Dec 31, 2014 | -$14.79M | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$319.00K | – |
| Q1 FY2026 | Mar 31, 2026 | -$1.10M | – |
| Q4 FY2025 | Dec 31, 2025 | -$822.00K | – |
| Q3 FY2025 | Sep 30, 2025 | -$257.00K | – |
| Q2 FY2025 | Jun 30, 2025 | -$2.03M | – |
| Q1 FY2025 | Mar 31, 2025 | -$1.59M | – |
| Q4 FY2024 | Dec 31, 2024 | -$2.21M | – |
| Q3 FY2024 | Sep 30, 2024 | -$1.75M | – |
| Q2 FY2024 | Jun 30, 2024 | -$2.46M | – |
| Q1 FY2024 | Mar 31, 2024 | -$3.21M | – |
| Q4 FY2023 | Dec 31, 2023 | -$4.15M | – |
| Q3 FY2023 | Sep 30, 2023 | -$2.89M | – |
| Q2 FY2023 | Jun 30, 2023 | -$4.80M | – |
| Q1 FY2023 | Mar 31, 2023 | -$3.47M | – |
| Q4 FY2022 | Dec 31, 2022 | -$2.36M | – |
| Q3 FY2022 | Sep 30, 2022 | -$3.37M | – |
| Q2 FY2022 | Jun 30, 2022 | -$3.37M | – |
| Q1 FY2022 | Mar 31, 2022 | -$4.89M | – |
| Q4 FY2021 | Dec 31, 2021 | -$6.66M | – |
| Q3 FY2021 | Sep 30, 2021 | -$8.27M | – |
| Q2 FY2021 | Jun 30, 2021 | -$6.23M | – |
| Q1 FY2021 | Mar 31, 2021 | -$4.71M | – |
| Q4 FY2020 | Dec 31, 2020 | -$6.75M | – |
| Q3 FY2020 | Sep 30, 2020 | -$6.92M | – |
| Q2 FY2020 | Jun 30, 2020 | -$7.28M | – |
| Q1 FY2020 | Mar 31, 2020 | -$9.27M | – |
| Q4 FY2019 | Dec 31, 2019 | -$5.01M | – |
| Q3 FY2019 | Sep 30, 2019 | -$3.76M | – |
| Q2 FY2019 | Jun 30, 2019 | -$4.46M | – |
| Q1 FY2019 | Mar 31, 2019 | -$3.97M | – |
| Q4 FY2018 | Dec 31, 2018 | -$2.70M | – |
| Q3 FY2018 | Sep 30, 2018 | -$4.02M | – |
| Q2 FY2018 | Jun 30, 2018 | -$4.30M | – |
| Q1 FY2018 | Mar 31, 2018 | -$2.62M | – |
| Q4 FY2017 | Dec 31, 2017 | -$2.68M | – |
| Q3 FY2017 | Sep 30, 2017 | -$2.37M | – |
| Q2 FY2017 | Jun 30, 2017 | -$4.39M | – |
| Q1 FY2017 | Mar 31, 2017 | -$4.53M | – |
| Q4 FY2016 | Dec 31, 2016 | -$4.28M | – |
| Q3 FY2016 | Sep 30, 2016 | -$3.93M | – |
See a number that looks wrong?